Searched for
OSTEOPOROSIS TREATMENT
Dr Reddy's gets European nod for biosimilar to treat osteoporosisProlia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk ...24 Nov, 2025, 05.34 PM IST- The silent disease affecting millions of men, and 4 powerful ways to fight it offThis silent disease weakens men's bones, leading to fractures. Around 2 million men in the US have it. Another 16 million have early bone l...30 Jun, 2025, 10.02 PM IST
- World Osteoporosis Day: This bone disease doesn’t have a cure. Watch out for early signs of brittle nails, neck painApproximately 200 mn people around the world are estimated to be affected by the disease.20 Oct, 2022, 09.58 AM IST
- Lupin inks licensing pact with Japan-based I'rom GroupDenosumab is indicated for the treatment of postmenopausal women with osteoporosis at high risk of fracture and prevention of skeletal-rela...25 Aug, 2022, 12.42 PM IST
- World Osteoporosis Day: Laziness is making your bones weak; healthy diet with milk, eggs & nuts will helpAdequate sleep of 6-8 hours daily is also essential for the body to repair.20 Oct, 2021, 01.39 PM IST
- Delhiites at high risk of suffering from brittle bonesNew Delhi, March 29 (IANS) A new study has found that people in the city are at a high risk of suffering from brittle bones which can cause...29 Mar, 2018, 03.52 PM IST
- Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...15 Nov, 2016, 07.30 PM IST
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...16 Sep, 2016, 05.02 PM IST
- Aurobindo Pharma gets final USFDA nod for osteoporosis drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...15 Mar, 2016, 12.04 PM IST
- Aurobindo gets USFDA nod to market generic Osteoporosis drugThe company has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Risedronate Sodium tablets, Au...01 Dec, 2015, 03.25 PM IST
- Aurobindo Pharma gains on USFDA approval for generic osteoporosis drugShares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug.31 Aug, 2015, 10.59 AM IST
- Aurobindo receives Australia nod for schizophrenia, osteoporosis drugsAurobindo Pharma has received approval from the Australian health authority to market Risperidone and Alendronate tablets.17 May, 2011, 02.25 PM IST
- Eli Lilly launches new drug administering deviceDrug firm ELi Lilly and Company today announced the launch of new drug administering device, used in the treatment of patient suffering fro...16 Apr, 2010, 10.21 PM IST
- Ranbaxy Lab's Romania unit to market osteoporosis drugPharma firm Ranbaxy Laboratories said its Romanian arm will market Evista, a drug used for treating osteoporosis.01 Sep, 2009, 03.22 PM IST
- Ranbaxy launches Bio-generic injectable for OsteoporosisRanbaxy Laboratories Ltd on Thursday announced the launch of 'BONISTA- Teriparatide' injection used in the treatment of Osteoporosis diseas...03 Apr, 2008, 01.54 PM IST
- Ranbaxy Labs launches Bonista-Teriparatide injection for OsteoporosisRanbaxy Laboratories has launched Bonista-Teriparatide injection for the treatment of Osteoporosis, in collaboration with Virchow Biotech, ...03 Apr, 2008, 12.33 PM IST
- Roche signs marketing pact with Elder PharmaRoche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.16 Dec, 2006, 02.19 AM IST
Load More
